BEROCCA Effervescent tablet is sweetened with aspartame, acesulfame-K and mannitol, therefore poses no dental risk. However, it is not recommended for person with phenylketonuria due to the source of phenylalanine (aspartame). It is suitable for diabetes patients. However, vitamin C may influence the laboratory test of glucose in the urine, although it has no effect on blood sugar levels. Therefore, it should not be taken several days before such tests are performed.
BEROCCA Effervescent tablet contains 272 mg sodium. Therefore, it is not recommended for patients with a low sodium diet.
BEROCCA Effervescent tablet contains the maximum daily dose of vitamin B6 (pyridoxine). Hence, do not exceed the recommended daily dose.
Risk benefits should be considered when the following medical problems exist: atrophic gastritis and disorder of the ileum or pancreas.